{
    "clinical_study": {
        "@rank": "36712", 
        "acronym": "S-PRP", 
        "arm_group": [
            {
                "arm_group_label": "T-PRP", 
                "arm_group_type": "Active Comparator", 
                "description": "532nm-short pulse panretinal photocoagulation with PASCAL function"
            }, 
            {
                "arm_group_label": "S-PRP", 
                "arm_group_type": "Experimental", 
                "description": "532nm-partially subthreshold short pulse panretinal photocoagulation with PASCAL endpoint management function"
            }
        ], 
        "brief_summary": {
            "textblock": "This randomized, parallel controlled, clinical-trial aims to evaluate the therapeutic\n      efficacy of 532nm laser partially subthreshold panretinal photocoagulation with PASCAL\n      endpoint management function for severe non-proliferative diabetic retinopathy."
        }, 
        "brief_title": "Safety and Effectiveness Study of 532nm Laser Subthreshold Panretinal Photocoagulation for Severe NPDR", 
        "completion_date": {
            "#text": "July 2014", 
            "@type": "Anticipated"
        }, 
        "condition": "Severe Non-proliferative Diabetic Retinopathy", 
        "condition_browse": {
            "mesh_term": [
                "Diabetic Retinopathy", 
                "Retinal Diseases"
            ]
        }, 
        "detailed_description": {
            "textblock": "This randomized, parallel controlled, clinical-trial aims to evaluate the therapeutic\n      efficacy of 532nm laser partially subthreshold panretinal photocoagulation with PASCAL\n      endpoint management function for severe non-proliferative diabetic retinopathy : (1)To\n      evaluate therapeutic effect of 532nm laser partially subthreshold panretinal\n      photocoagulation with PASCAL endpoint management function for severe non-proliferative\n      diabetic retinopathy; (2)To compare side effect of 532nm laser partially subthreshold\n      panretinal photocoagulation with PASCAL endpoint management function on retina with\n      traditional visible endpoint panretinal photocoagulation."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Diagnosis of severe non-proliferative diabetic retinopathy\n\n          -  Age:45-80 years\n\n          -  Best corrected visual acuity(BCVA) \u226520/100,Myopia\u2264-6 degree(-6D)\n\n          -  No photocoagulation (PRP) before this clinical trial and no major ocular surgery\n             (including cataract extraction, or any other intraocular surgery) within 3 months\n\n          -  Ability and willingness to provide informed consent\n\n        Exclusion Criteria:\n\n          -  Participate in other clinical trials within 3 months\n\n          -  Severe refractive media turbidity; Unable to accept laser treatment such as\n             nystagmus, etc\n\n          -  Medically or mentally unstable(including cardiovascular disorders, cerebrovascular\n             diseases,liver and kidney disease,hematological disorder and psychosis\n\n          -  Conditions that in the opinion of the investigator would interfere trial results or\n             increase risk\n\n          -  Conditions that in the opinion of the investigator would preclude participation in\n             the study"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "80 Years", 
            "minimum_age": "45 Years"
        }, 
        "enrollment": {
            "#text": "84", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "December 18, 2012", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01759121", 
            "org_study_id": "S-PASCAL-PRP", 
            "secondary_id": "ChiCTR-TRC-12002735"
        }, 
        "intervention": [
            {
                "arm_group_label": "T-PRP", 
                "description": "532nm-short pulse panretinal photocoagulation with PASCAL function", 
                "intervention_name": "T-PRP", 
                "intervention_type": "Radiation", 
                "other_name": "Traditional-PRP"
            }, 
            {
                "arm_group_label": "S-PRP", 
                "description": "532nm-partially subthreshold short pulse panretinal photocoagulation with PASCAL endpoint management function", 
                "intervention_name": "S-PRP", 
                "intervention_type": "Radiation", 
                "other_name": "Subthreshold PRP"
            }
        ], 
        "is_fda_regulated": "No", 
        "keyword": [
            "severe non-proliferative diabetic retinopathy", 
            "subthreshold", 
            "panretinal photocoagulation", 
            "PASCAL", 
            "endpoint management"
        ], 
        "lastchanged_date": "January 1, 2013", 
        "link": {
            "description": "a clinical study on subthreshold panretinal photocoagulation for proliferative diabetic retinopathy (PDR)", 
            "url": "http://www.nature.com/eye/journal/v22/n5/full/6702725a.html"
        }, 
        "location": {
            "contact": {
                "email": "ree04@126.com", 
                "last_name": "Peipei Wu", 
                "phone": "13602457876"
            }, 
            "facility": {
                "address": {
                    "city": "Guangzhou", 
                    "country": "China", 
                    "state": "Guangdong", 
                    "zip": "510060"
                }, 
                "name": "Zhongshan Ophthalmic Center, Sun Yat-sen University"
            }, 
            "investigator": [
                {
                    "last_name": "Chen-jin Jin", 
                    "role": "Principal Investigator"
                }, 
                {
                    "last_name": "Peipei Wu", 
                    "role": "Sub-Investigator"
                }
            ], 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "China"
        }, 
        "number_of_arms": "2", 
        "official_title": "Randomized, Parallel Controlled, Clinical-trial on 532nm Laser Partially Subthreshold Panretinal Photocoagulation With PASCAL Endpoint Management Function for Severe Non-proliferative Diabetic Retinopathy(NPDR)", 
        "overall_contact": {
            "email": "ree04@126.com", 
            "last_name": "Pei-pei Wu", 
            "phone": "13602457876"
        }, 
        "overall_official": [
            {
                "affiliation": "Zhongshan Ophthalmic Center, Sun Yat-sen University", 
                "last_name": "Chen-jin Jin", 
                "role": "Study Director"
            }, 
            {
                "affiliation": "Zhongshan Ophthalmic Center, Sun Yat-sen University", 
                "last_name": "Pei-pei Wu", 
                "role": "Principal Investigator"
            }
        ], 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "China: Ethics Committee", 
            "has_dmc": "Yes"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "July 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": [
            {
                "description": "best corrected visual acuity", 
                "measure": "change of best corrected visual acuity", 
                "safety_issue": "Yes", 
                "time_frame": "1 year"
            }, 
            {
                "measure": "the probability of vitreous haemorrhage", 
                "safety_issue": "No", 
                "time_frame": "1 year"
            }
        ], 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01759121"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Sun Yat-sen University", 
            "investigator_full_name": "Jin Chen-jin", 
            "investigator_title": "Dr", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": [
            {
                "measure": "Central Retinal Thickness", 
                "safety_issue": "Yes", 
                "time_frame": "1 year"
            }, 
            {
                "measure": "foveal volume of macula", 
                "safety_issue": "Yes", 
                "time_frame": "1 year"
            }, 
            {
                "measure": "amount of microaneurysms", 
                "safety_issue": "No", 
                "time_frame": "1 year"
            }, 
            {
                "measure": "amount of bard exudate", 
                "safety_issue": "No", 
                "time_frame": "1 year"
            }, 
            {
                "measure": "amount of retinal hemorrhage", 
                "safety_issue": "No", 
                "time_frame": "1 year"
            }, 
            {
                "measure": "amount and area of IRMA", 
                "safety_issue": "No", 
                "time_frame": "1 year"
            }, 
            {
                "measure": "amount of neovascularization", 
                "safety_issue": "No", 
                "time_frame": "1 year"
            }, 
            {
                "measure": "change of ischemia area", 
                "safety_issue": "No", 
                "time_frame": "1 year"
            }
        ], 
        "source": "Sun Yat-sen University", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Sun Yat-sen University", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "December 2012", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Outcomes Assessor), Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "December 2012"
    }
}